.png){kind=logo}
Botanical Innovation for Cancer Care
NatureCeuticals is a clinical-stage botanical pharmaceutical company developing evidence-based oncology supportive care therapies, led by Nuvastatic™, a botanical medicine that has successfully completed Phase III clinical evaluation for cancer-related fatigue.
Redefining Cancer Supportive Care
Derived by nature, defined by science
NatureCeuticals develops clinically validated botanical medicines to support patients throughout their cancer journey. Combining pharmaceutical innovation with nature-derived science, we are committed to improving quality of life through evidence-based supportive care therapies.
Our Research
NatureCeuticals is dedicated to advancing evidence-based botanical medicines for cancer care.
Through rigorous scientific research and clinical development, we develop innovative therapies that improve quality of life, support cancer treatment, and address unmet medical needs. Our flagship program, Nuvastatic™, has completed Phase III clinical evaluation in cancer-related fatigue.
Research Focus Areas
• Cancer-Related Fatigue and Quality of Life assessment in Stage 1, 2 and 3 breast cancer patients receiving first-line chemotherapy. (Study Completed)
• Cancer-Related Fatigue and Quality of Life assessment in Stage 1, 2 and 3 colon cancer patients receiving first-line chemotherapy. (Study in Process of completion)
• Metastatic stage 4 colon cancer on standard chemotherapy to assess tumour response, Cancer-Related Fatigue and Quality of Life.
• Metastatic stage 4 Triple Negative Breast Cancer on standard chemotherapy to assess tumour response, Cancer-Related Fatigue and Quality of Life.
Products Developed
From treatment support and symptom management to nutritional care, NatureCeuticals is developing innovative evidence-based botanical solutions to improve outcomes and quality of life for cancer patients.
1
Adjunctive Therapeutics
Nuvastatic™ 300
A proprietary nano-formulated botanical medicine being developed as an adjunctive therapy for cancer treatment. Nuvastatic™ 300 is currently undergoing Phase III clinical evaluation in patients with advanced metastatic breast cancer and advanced metastatic colorectal cancer.
The program is designed to support treatment outcomes while maintaining an excellent safety profile through a scientifically standardised rosmarinic acid-rich botanical formulation.
Status: Phase III Clinical Development
2
Cancer Supportive Care
Nuvastatic™
A clinically validated botanical medicine developed to reduce cancer-related fatigue and improve quality of life in patients undergoing cancer treatment.
Nuvastatic™ has successfully completed Phase III clinical evaluation in breast cancer patients receiving chemotherapy and is currently being further evaluated in additional oncology populations.
The program aims to help patients maintain physical function, wellbeing, and treatment adherence throughout their cancer journey.
Status: Phase III Completed / Ongoing Clinical Development
3
Oncology Nutrition Support
Nuvastatic Life™
An oncology-focused nutritional support program combining Nuvastatic active ingredients, Lanctos 75™, vitamins, minerals, and essential nutrients to support the nutritional needs of cancer patients.
Developed to complement supportive care strategies, Nuvastatic Life™ is designed to help patients maintain nutritional status, strength, and quality of life during treatment and recovery.
Status: Commercial Development
Our Story
Get to Know Us
NatureCeuticals was founded to transform botanical science into clinically validated medicines that improve the lives of cancer patients.
Building on decades of research in natural product pharmacology, we have developed a portfolio of oncology-focused programs spanning cancer therapeutics, supportive care, and nutritional support. From laboratory discovery to Phase III clinical studies, our mission is to deliver innovative, evidence-based botanical solutions that address unmet needs in cancer care.
